• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Signify Health Inc.

    2/11/22 4:03:03 PM ET
    $SGFY
    Retail: Computer Software & Peripheral Equipment
    Technology
    Get the next $SGFY alert in real time by email
    SC 13G 1 d252514dsc13g.htm SC 13G SC 13G

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. )*

     

     

    Signify Health, Inc.

    (Name of Issuer)

    Class A Common Stock, par value $0.01 per share

    (Title of Class of Securities)

    82671G100

    (CUSIP Number)

    December 31, 2021

    (Date of Event which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☒ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 82671G100

     

      1    

      NAMES OF REPORTING PERSONS

     

      New Mountain Partners V (AIV-C2), L.P.

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☒        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      48,378,865

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      48,378,865

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      48,378,865

    10  

      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

      28.4%(1)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      PN

     

    (1) 

    Calculated under Rule 13d-3 of the Securities Exchange Act of 1934. Please see Item 4.

     

    2


    CUSIP No. 82671G100

     

      1    

      NAMES OF REPORTING PERSONS

     

      Remedy Acquisition, L.P.

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☒        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      48,330,828

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      48,330,828

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      48,330,828

    10  

      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

      28.4%(1)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      PN

    (1) Calculated under Rule 13d-3 of the Securities Exchange Act of 1934. Please see Item 4.

     

    3


    CUSIP No. 82671G100

     

      1    

      NAMES OF REPORTING PERSONS

     

      New Mountain Partners V (AIV-C), L.P.

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☒        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      42,905,113

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      42,905,113

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      42,905,113

    10  

      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

      20.1%(1)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      PN

     

    (1) 

    Calculated under Rule 13d-3 of the Securities Exchange Act of 1934. Please see Item 4.

     

    4


    CUSIP No. 82671G100

     

      1    

      NAMES OF REPORTING PERSONS

     

      Remedy Investment GP, LLC

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☒        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      48,330,828

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      48,330,828

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      48,330,828

    10  

      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

      28.4%(1)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      PN

     

    (1) 

    Calculated under Rule 13d-3 of the Securities Exchange Act of 1934. Please see Item 4.

     

    5


    CUSIP No. 82671G100

     

      1    

      NAMES OF REPORTING PERSONS

     

      New Mountain Partners V, L.P.

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☒        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      48,330,828

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      48,330,828

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      48,330,828

    10  

      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

      28.4%(1)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      PN

     

    (1) 

    Calculated under Rule 13d-3 of the Securities Exchange Act of 1934. Please see Item 4.

     

    6


    CUSIP No. 82671G100

     

      1    

      NAMES OF REPORTING PERSONS

     

      New Mountain Investments V, L.L.C.

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☒        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      139,614,806

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      139,614,806

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      139,614,806

    10  

      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

      65.4%(1)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      OO

     

    (1) 

    Calculated under Rule 13d-3 of the Securities Exchange Act of 1934. Please see Item 4.

     

    7


    CUSIP No. 82671G100

     

      1    

      NAMES OF REPORTING PERSONS

     

      New Mountain Capital, L.L.C.

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☒        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      139,638,554

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      139,638,554

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      139,638,554

    10  

      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

      65.5%(1)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      OO

     

    (1) 

    Calculated under Rule 13d-3 of the Securities Exchange Act of 1934. Please see Item 4.

     

    8


    CUSIP No. 82671G100

     

      1    

      NAMES OF REPORTING PERSONS

     

      New Mountain Capital Group, L.P.

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☒        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      139,638,554

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      139,638,554

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      139,638,554

    10  

      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

      65.5%(1)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      PN

     

    (1) 

    Calculated under Rule 13d-3 of the Securities Exchange Act of 1934. Please see Item 4.

     

    9


    CUSIP No. 82671G100

     

      1    

      NAMES OF REPORTING PERSONS

     

      NM Holdings GP, L.L.C.

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☒        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      139,638,554

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      139,638,554

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      139,638,554

    10  

      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

      65.5%(1)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      OO

     

    (1) 

    Calculated under Rule 13d-3 of the Securities Exchange Act of 1934. Please see Item 4.

     

    10


    CUSIP No. 82671G100

     

      1    

      NAMES OF REPORTING PERSONS

     

      Steven B. Klinsky

      2  

      CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

      (a)  ☒        (b)  ☐

     

      3  

      SEC USE ONLY

     

      4  

      CITIZENSHIP OR PLACE OF ORGANIZATION

     

      United States of America

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5    

      SOLE VOTING POWER

     

      0

       6  

      SHARED VOTING POWER

     

      139,638,554

       7  

      SOLE DISPOSITIVE POWER

     

      0

       8  

      SHARED DISPOSITIVE POWER

     

      139,638,554

      9    

      AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

      139,638,554

    10  

      CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

     

      ☐

    11  

      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

      65.5%(1)

    12  

      TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

     

      IN

     

    (1) 

    Calculated under Rule 13d-3 of the Securities Exchange Act of 1934. Please see Item 4.

     

    11


    Item 1(a). Name of Issuer:

    Signify Health, Inc. (the “Issuer”)

    Item 1(b). Address of Issuer’s Principal Executive Offices:

    800 Connecticut Avenue

    Norwalk, CT 06854

    Item 2(a). Name of Person Filing:

    This Schedule 13G (this “Statement”) is filed on behalf of each the following persons (collectively, the “Reporting Persons”):

     

      i.

    New Mountain Partners V (AIV-C2), L.P.

     

      ii.

    Remedy Acquisition, L.P.

     

      iii.

    New Mountain Partners V (AIV-C), L.P.

     

      iv.

    Remedy Investment GP, LLC

     

      v.

    New Mountain Partners V, L.P.

     

      vi.

    New Mountain Investments V, L.L.C

     

      vii.

    New Mountain Capital, L.L.C.

     

      viii.

    New Mountain Capital Group, L.P.

     

      ix.

    NM Holdings GP, L.L.C.

     

      x.

    Steven B. Klinsky

    Item 2(b). Address of Principal Business Office or, if None, Residence:

    1633 Broadway, 48th Floor

    New York, NY 10019

    Item 2(c). Citizenship:

    The citizenship of each Reporting Person is set out in Item 4 of its cover page.

    Item 2(d). Title of Class of Securities:

    Class A Common Stock, par value $0.01 per share (the “Class A Common Stock”)

    Item 2(e). CUSIP Number:

    82671G100

    Item 3. If This Statement is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:

    Not applicable.

    Item 4. Ownership:

    The information required by Items 4(a)-4(c) is set forth in Rows 5-11 of the cover page for each of the Reporting Persons and is incorporated herein by reference for each of the Reporting Persons.

    New Mountain Partners V (AIV-C2), L.P. (“AIV-C2”) directly holds 48,378,865 shares of Class A Common Stock, Remedy Acquisition, L.P. (“Remedy Acquisition”) directly holds 48,330,828 shares of Class A Common Stock and New Mountain Partners V (AIV-C), L.P. (“AIV-C”) directly holds 42,905,113 Units of Cure TopCo LLC (the “LLC Units”) which may be redeemed, together with the cancellation of a share of Class B common stock of the Issuer, at any time following the Issuer’s initial public offering for one share of Class A Common Stock or a cash payment equal to the volume weighted average market price of one share of Class A Common Stock for each LLC Unit redeemed.

     

    12


    Each of Matthew S. Holt, Albert A. Notini and Kyle B. Peterson (collectively, the “New Mountain Directors”) are members of New Mountain Investments V, L.L.C. (“NM V”) and each serves as a director of the Issuer. Each New Mountain Director was granted restricted stock units (“RSUs”) relating to 7,916 shares of Class A Common Stock. Such RSUs vest on February 16, 2022. Each of the New Mountain Directors has assigned all rights, title and interest in the RSUs to New Mountain Capital, L.L.C. (“NMC”).

    The general partner of Remedy Acquisition is Remedy Investment GP, LLC, a wholly owned subsidiary of New Mountain Partners V, L.P. The general partner of New Mountain Partners V, L.P. is NM V.

    The general partner of both AIV-C and AIV-C2 is NM V and the manager of both such entities is NMC. Steven B. Klinsky is the managing member of NM V, which has decision-making power over the disposition and voting of shares of portfolio investments of AIV-C and AIV-C2. NMC also has voting power over the shares of portfolio investments of AIV-C and AIV-C2. Mr. Klinsky, as the managing member of NM V.

    The managing member of NMC is New Mountain Capital Group, L.P. The general partner of New Mountain Capital Group, L.P. is NM Holdings GP, L.L.C. Steven B. Klinsky is the managing member of NM Holdings GP, L.L.C.

    Calculation of the percentage of Class A Common Stock beneficially owned is based on 170,420,536 shares of Class A Common Stock outstanding as of October 31, 2021, as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 10, 2021 and includes shares of Class A Common Stock deliverable upon the redemption of the LLC Units, as applicable.

    Item 5. Ownership of Five Percent or Less of a Class:

    Not applicable.

    Item 6. Ownership of More than Five Percent on Behalf of Another Person:

    Not applicable.

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person:

    Not applicable.

    Item 8. Identification and Classification of Members of the Group:

    Not applicable.

    Item 9. Notice of Dissolution of Group:

    Not applicable.

    Item 10. Certification:

    Not applicable.

     

    13


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: February 11, 2022

     

    NEW MOUNTAIN PARTNERS V (AIV-C2), L.P.
    By: New Mountain Investments V, L.L.C., its
    general partner
    By:  

    /s/ Steven B. Klinsky

    Name:   Steven B. Klinsky
    Title:   Managing Member
    REMEDY ACQUISITION, L.P.
    By: Remedy Investment GP, LLC, its general partner
    By: New Mountain Partners V, L.P., its sole member
    By: New Mountain Investments V, L.L.C., its
    general partner
    By:  

    /s/ Steven B. Klinsky

    Name:   Steven B. Klinsky
    Title:   Managing Member
    NEW MOUNTAIN PARTNERS V (AIV-C), L.P.
    By: New Mountain Investments V, L.L.C., its
    general partner
    By:  

    /s/ Steven B. Klinsky

    Name:   Steven B. Klinsky
    Title:   Managing Member
    REMEDY INVESTMENT GP, LLC
    By: New Mountain Partners V, L.P., its sole member
    By: New Mountain Investments V, L.L.C., its
    general partner
    By:  

    /s/ Steven B. Klinsky

    Name:   Steven B. Klinsky
    Title:   Managing Member


    NEW MOUNTAIN PARTNERS V, L.P.
    By: New Mountain Investments V, L.L.C., its
    general partner
    By:  

    /s/ Steven B. Klinsky

    Name:   Steven B. Klinsky
    Title:   Managing Member
    NEW MOUNTAIN INVESTMENTS V, L.L.C.
    By:  

    /s/ Steven B. Klinsky

    Name:   Steven B. Klinsky
    Title:   Managing Member
    NEW MOUNTAIN CAPITAL, L.L.C.
    By: New Mountain Capital Group, L.P., its managing
    member
    By: NM Holdings GP, L.L.C., its general partner
    By:  

    /s/ Steven B. Klinsky

    Name:   Steven B. Klinsky
    Title:   Managing Member
    NEW MOUNTAIN CAPITAL GROUP, L.P.
    By: NM Holdings GP, L.L.C., its general partner
    By:  

    /s/ Steven B. Klinsky

    Name:   Steven B. Klinsky
    Title:   Managing Member
    NM HOLDINGS GP, L.L.C.
    By:  

    /s/ Steven B. Klinsky

    Name:   Steven B. Klinsky
    Title:   Managing Member

    /s/ Steven B. Klinsky

    Steven B. Klinsky


    EXHIBIT LIST

     

    Exhibit A    Joint Filing Agreement, dated as of February 11, 2022 (filed herewith)

     

    Get the next $SGFY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SGFY

    DatePrice TargetRatingAnalyst
    8/31/2022$35.00Buy
    BTIG Research
    7/29/2022$18.00Sector Perform
    RBC Capital Mkts
    5/16/2022$19.00 → $16.00Neutral → Outperform
    Robert W. Baird
    3/30/2022$36.00Buy
    Guggenheim
    3/9/2022$27.00 → $18.00Market Perform
    Cowen & Co.
    3/9/2022$20.00 → $21.00Neutral → Buy
    UBS
    3/7/2022$34.00 → $27.00Overweight
    Piper Sandler
    2/11/2022$20.00Buy
    Goldman Sachs
    More analyst ratings

    $SGFY
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • CVS Health to Close Acquisition of Signify Health

      WOONSOCKET, R.I. and DALLAS and NEW YORK, March 27, 2023 /PRNewswire/ -- CVS Health® (NYSE:CVS) today announced it expects to complete its acquisition of Signify Health (NYSE:SGFY) on or around March 29, 2023, subject to the satisfaction or waiver of the remaining customary closing conditions set forth in the merger agreement. The companies entered into a definitive agreement in September 2022 under which CVS Health announced it would acquire Signify Health for $30.50 per share in cash for a total transaction value of approximately $8 billion. Upon completion of the acquisitio

      3/27/23 6:45:00 AM ET
      $CVS
      $SGFY
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Cardinal Health's Outcomes™ collaborates with Signify Health to offer in-home medication therapy management

      DUBLIN, Ohio, March 6, 2023 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today announced its collaboration with Signify Health (NYSE:SGFY) to offer in-home clinical and medication management services through its Outcomes™ business. This collaboration will help reduce costs and eliminate gaps in care for more than 2.3 million members nationwide to support their treatment journey from prescription to pharmacy to home. Studies have shown that many members do not take their medications as prescribed. Bringing together Signify Health's1 mobile network of 11,000+ credentialed clinicia

      3/6/23 9:03:00 AM ET
      $CAH
      $SGFY
      Other Pharmaceuticals
      Health Care
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Addus HomeCare Names Heather Dixon to Board of Directors

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced that Heather Dixon, CPA, has been appointed to the Company's Board of Directors as an independent board member, effective March 1, 2023. She fills the seat previously held by Steven Geringer and will serve as a member of the Audit Committee. Dixon currently serves as Chief Financial Officer of Everside Health, one of the nation's largest direct primary care providers. In this role, she provides financial oversight and strategic direction with a focus on growth and innovation within the direct primary care space. Prior to joining Everside, she was the Senior Vice President, Global Controller and Chie

      3/1/23 8:00:00 AM ET
      $ADUS
      $SGFY
      Medical/Nursing Services
      Health Care
      Retail: Computer Software & Peripheral Equipment
      Technology

    $SGFY
    SEC Filings

    See more
    • SEC Form 15-12G filed by Signify Health Inc.

      15-12G - Signify Health, Inc. (0001828182) (Filer)

      4/10/23 8:00:50 AM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form 25-NSE filed by Signify Health Inc.

      25-NSE - Signify Health, Inc. (0001828182) (Subject)

      3/29/23 1:33:54 PM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form S-8 POS filed by Signify Health Inc.

      S-8 POS - Signify Health, Inc. (0001828182) (Filer)

      3/29/23 9:06:55 AM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology

    $SGFY
    Leadership Updates

    Live Leadership Updates

    See more

    $SGFY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Type 2 Diabetes Reversal Leader Virta Health Appoints Shane Henderson as Chief Technology Officer

      A 30+ year industry veteran from Signify Health and Match.com, Shane joins to scale Virta's technology platform amid triple-digit year-over-year growth Today, diabetes reversal leader Virta Health announced the addition of Shane Henderson as Chief Technology Officer (CTO). With over three decades of experience at companies like Signify Health and Match.com, Shane joins to scale Virta's technology through continued triple-digit growth and surging demand for its innovative approach to treating metabolic diseases like type 2 diabetes, prediabetes, and obesity. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220510006160/en/As CTO, S

      5/10/22 12:14:00 PM ET
      $MTCH
      $SGFY
      Computer Software: Programming Data Processing
      Technology
      Retail: Computer Software & Peripheral Equipment
    • GoodCell Appoints Chris Garcia as New CEO

      WALTHAM, Mass., Sept. 1, 2021 /PRNewswire/ -- GoodCell, a medically-actionable health technology service to proactively identify, track and address health risks, today announces it has appointed Chris Garcia as its new Chief Executive Officer and member of the Board of Directors, effective immediately. In his new role, Mr. Garcia will work to scale GoodCell's commercial strategy, while founder Trevor Perry will assume the title of President and remain as a director of the company. "The Board of Directors and I are excited to have Chris lead our organization into its next chapter of development," said Mr. Perry.  "Chris' addition validates the value of what we have built at GoodCell to date a

      9/1/21 12:00:00 PM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Signify Health Appoints Seasoned Tech Executive Arnold Goldberg to Board of Directors

      Signify Health, Inc. (NYSE:SGFY), a leading value-based healthcare platform that leverages advanced analytics, technology and nationwide healthcare provider networks, today announced the appointment of Arnold Goldberg as an independent member of its board of directors, serving on the audit committee. Most recently serving as Senior Vice President, Chief Product Architect and Senior Technologist at PayPal, Mr. Goldberg brings deep knowledge of platform architecture and product strategy to Signify Health, as well as valuable experience leading and scaling teams of technologists for some of the biggest and most groundbreaking technology companies of the past two decades. This press release fea

      8/25/21 4:35:00 PM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form 4 filed by Builder Josh

      4 - Signify Health, Inc. (0001828182) (Issuer)

      3/29/23 9:07:54 AM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form 4 filed by Armbrester Bradford Kyle

      4 - Signify Health, Inc. (0001828182) (Issuer)

      3/29/23 9:03:24 AM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form 4 filed by Rothman Marc D

      4 - Signify Health, Inc. (0001828182) (Issuer)

      3/29/23 9:02:41 AM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology

    $SGFY
    Financials

    Live finance-specific insights

    See more
    • CVS Health to Acquire Signify Health

      Advances long-term strategy by providing platform for growth in value-based care WOONSOCKET, R.I., DALLAS and NEW YORK, Sept. 5, 2022 /PRNewswire/ -- CVS Health® (NYSE:CVS) and Signify Health (NYSE:SGFY) ("Signify") have entered into a definitive agreement under which CVS Health will acquire Signify Health for $30.50 per share in cash, representing a total transaction value of approximately $8 billion. Signify Health is a leader in Health Risk Assessments, value-based care and provider enablement. With a network of more than 10,000 clinicians across all 50 states and a nationw

      9/5/22 5:00:00 PM ET
      $CVS
      $SGFY
      Retail-Drug Stores and Proprietary Stores
      Consumer Staples
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Signify Health Announces Second Quarter 2022 Results

      Financial Highlights Second Quarter 2022: Revenue of $246.2 million, an increase of 16% from second quarter 2021 GAAP net loss of $490.0 million, which includes a $519.9 million loss on impairment related to our decision to exit the Episodes of Care Services segment. Non-GAAP adjusted EBITDA1 of $62.6 million, an increase of 15% from second quarter 2021 2022 Guidance: Signify Health is providing guidance for full year 2022 as follows: Home & Community Services (HCS) segment revenue in the range of $800 million to $810 million; Revenue from the Caravan Health acquisition in the range of $45 million to $48 million; Adjusted EBITDA margin1 for HCS and Caravan Health of 29% to 3

      8/3/22 4:35:00 PM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Signify Health to Report Second Quarter 2022 Earnings and Host Earnings Call on Thursday, August 4, 2022

      Signify Health, Inc. (NYSE:SGFY), a leading value-based healthcare platform enabled by advanced analytics, technology and nationwide healthcare networks, announced that it will release its financial results for the second quarter 2022 after the market closes on Wednesday, August 3, 2022, and will hold a conference call at 8:30am ET on Thursday, August 4, 2022 to discuss the results. Pre-registration is required for participation in the conference call. Please follow the link below to pre-register. After registering, you will be provided with your access details via email. http://www.incommuk.com/customers/signifyhealthquartertwo2022 A webcast of the conference call will also be available

      7/20/22 4:35:00 PM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology

    $SGFY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Signify Health Inc. (Amendment)

      SC 13G/A - Signify Health, Inc. (0001828182) (Subject)

      2/1/23 4:31:29 PM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form SC 13G filed by Signify Health Inc.

      SC 13G - Signify Health, Inc. (0001828182) (Subject)

      2/11/22 4:03:03 PM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology
    • SEC Form SC 13G/A filed by Signify Health Inc. (Amendment)

      SC 13G/A - Signify Health, Inc. (0001828182) (Subject)

      2/9/22 3:00:56 PM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology

    $SGFY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BTIG Research initiated coverage on Signify Health with a new price target

      BTIG Research initiated coverage of Signify Health with a rating of Buy and set a new price target of $35.00

      8/31/22 7:23:52 AM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology
    • RBC Capital Mkts initiated coverage on Signify Health with a new price target

      RBC Capital Mkts initiated coverage of Signify Health with a rating of Sector Perform and set a new price target of $18.00

      7/29/22 7:24:40 AM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology
    • Signify Health upgraded by Robert W. Baird with a new price target

      Robert W. Baird upgraded Signify Health from Neutral to Outperform and set a new price target of $16.00 from $19.00 previously

      5/16/22 7:32:22 AM ET
      $SGFY
      Retail: Computer Software & Peripheral Equipment
      Technology